Renal Anemia
Introduction:Renal anemia is a common complication of chronic kidney disease (CKD) where the kidneys fail to produce adequate erythropoietin, leading to reduced red blood cell production. Symptoms include fatigue, pallor, and reduced exercise tolerance.
Treatment Options:
Erythropoiesis-Stimulating Agents (ESAs): Drugs like epoetin alfa stimulate red blood cell production.
Iron Supplementation: Oral or intravenous iron addresses iron deficiency often accompanying renal anemia.
Blood Transfusions: Used in severe cases or when rapid correction is needed.
Novel Therapies: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are emerging treatments improving hemoglobin levels with oral administration.
Future Outlook:Advances aim to improve efficacy while reducing cardiovascular risks associated with high-dose ESAs. Personalized anemia management in CKD is gaining momentum.